Pathogenesis of Candida glabrata in the Urinary Tract
尿道光滑念珠菌的发病机制
基本信息
- 批准号:7868931
- 负责人:
- 金额:$ 2.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-20 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdherenceAmino AcidsBacterial AdhesinsBindingBiochemicalBloodCandidaCandida albicansCandida glabrataCandidiasisCell surfaceCellsClone CellsCollaborationsDNA BindingDisseminated candidiasisEnzymesEosinophil-Derived NeurotoxinFamilyFamily memberGene ExpressionGene Expression RegulationGene FamilyGenesGeneticGenetic TranscriptionGrantGrowthHaploidyHistone DeacetylaseHistonesHumanInfectionLigand Binding DomainLigandsMediatingMediator of activation proteinModelingNiacinamideNicotinic AcidsOligonucleotide MicroarraysOrganismPathogenesisProcessRegulationReporterResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRoleSaccharomycetalesSignal TransductionSpecificityStreamSystemTestingTherapeutic InterventionUnited StatesUrinary tractUrineVirulenceVirulence FactorsVitaminsWorkYeastsactivating transcription factorasexualbasederepressiongenetic analysisimprovedinsightinterestmutantnovelpathogenprogramspromoterresponsesugartooltranscription factor
项目摘要
DESCRIPTION (provided by applicant): The long-term objective of this application is a comprehensive analysis of virulence factors in pathogenic yeast required for colonization and persistence in the urinary tract. Candida glabrata and Candida albicans are the two major organisms responsible for funguria, as well as disseminated candidiasis. Little is known about the factors that allow Candida to colonize or persist in the urinary tract. Unlike C. albicans, C. glabrata is haploid making it an excellent model for genetic analysis of virulence using already established genetic tools. We have exploited this to identify and to begin to characterize the function and regulation of genes implicated in experimental UTI. We have previously identified an adhesin EPA6 that is specifically induced during UTI, and provided evidence that it is regulated by a novel mechanism in which limiting environmental levels of nicotinic acid, a precursor of NAD+, leads to derepression of EPA6 gene transcription.
We propose to build on these results in several ways. First, we propose to analyze the importance of NA-limitation as a general signal for C. glabrata gene regulation in the urinary tract. As part of this, we will determine if other NA-regulated genes (regulated by two NAD* dependent histone deacetylases Sir2 and Hst1) are in fact induced during UTI. We also hypothesize that regulation by NA limitation acts with other transcription factors to control EPA6 transcription and propose to identify some of these factors. We have evidence that Hst1- and Sir2 regulated genes respond to different levels of NA, and hypothesize that different levels of NA limitation can signal to the cell by differential effects on Sir2 and Hst1, as a result of differences in the Km of the two enzymes for NAD*. Secondly, we propose that NA-regulated genes impact UTI virulence. We hypothesize that EPA6 and five other EPA adhesins are induced during UTI, and that these act in combination in colonization of the urinary tract. In addition, we hypothesize and will test whether three HSH1-regulated genes, which encode transporters of NAD* precursors, are critical in UTI virulence.
These approaches will provide insight into significant aspects of the yeast-host interaction and an improved understanding of the processes contributing to fungal UTI, with the ultimate aim of enhancing therapeutic intervention.
描述(由申请人提供):本申请的长期目标是全面分析致病酵母中的毒力因素,这些因素是在尿路中定植和持续存在所需的。光滑念珠菌和白色念珠菌是引起真菌尿和播散性念珠菌病的两种主要微生物。人们对念珠菌在尿路中定植或存活的因素知之甚少。与白色念珠菌不同,光滑念珠菌是单倍体,这使其成为利用已建立的遗传工具进行毒力遗传分析的极佳模型。我们已经利用这一点来鉴定并开始表征与实验性尿路感染有关的基因的功能和调节。我们以前已经发现了一种粘附素EPA6,它是在UTI过程中特异性诱导的,并提供了证据表明,它受到一种新的机制的调节,在这种机制中,限制环境中NAD+的前体烟酸水平会导致EPA6基因转录的去抑制。
我们建议在这些结果的基础上采取几种方式。首先,我们建议分析NA限制作为尿路中光滑念珠菌基因调控的一般信号的重要性。作为这项工作的一部分,我们将确定其他NA调节的基因(由两个依赖于NAD*的组蛋白去乙酰基酶Sir2和Hst1调控)是否实际上在尿路感染期间被诱导。我们还假设NA限制的调节作用与其他转录因子一起控制EPA6的转录,并建议确定其中一些因子。我们有证据表明,Hst1和Sir2调控的基因对不同水平的NA做出反应,并假设不同水平的NA限制可以通过对Sir2和Hst1的不同影响向细胞发出信号,这是两种酶对NAD*的Km不同的结果。其次,我们提出NA调节基因影响UTI毒力。我们假设EPA6和其他五种EPA粘附素是在尿路感染期间诱导的,并且这些粘附素共同作用于尿路定植。此外,我们假设并将测试编码NAD*前体转运蛋白的三个HSH1调节基因是否在UTI毒力中起关键作用。
这些方法将提供对酵母-宿主相互作用的重要方面的洞察,并更好地理解导致真菌UTI的过程,最终目的是加强治疗干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brendan Cormack其他文献
Brendan Cormack的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brendan Cormack', 18)}}的其他基金
Cryptococcus neoformans factors contributing to penetration of the blood-brain barrier
新型隐球菌穿透血脑屏障的因素
- 批准号:
10170285 - 财政年份:2020
- 资助金额:
$ 2.8万 - 项目类别:
Cryptococcus neoformans factors contributing to penetration of the blood-brain barrier
新型隐球菌穿透血脑屏障的因素
- 批准号:
10079284 - 财政年份:2020
- 资助金额:
$ 2.8万 - 项目类别:
Molecular mechanism that suppresses the proliferation of cells with supernumerary centrioles
抑制多余中心粒细胞增殖的分子机制
- 批准号:
10458557 - 财政年份:2019
- 资助金额:
$ 2.8万 - 项目类别:
AIDS Opportunistic Pathogens: Targeting the Methyl Citrate Cycle
艾滋病机会病原体:针对柠檬酸甲酯循环
- 批准号:
7620189 - 财政年份:2009
- 资助金额:
$ 2.8万 - 项目类别:
AIDS Opportunistic Pathogens: Targeting the Methyl Citrate Cycle
艾滋病机会病原体:针对柠檬酸甲酯循环
- 批准号:
7911623 - 财政年份:2009
- 资助金额:
$ 2.8万 - 项目类别:
Pathogenesis of Candida glabrata in the Urinary Tract
尿道光滑念珠菌的发病机制
- 批准号:
8062115 - 财政年份:2007
- 资助金额:
$ 2.8万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 2.8万 - 项目类别:
Fellowship Programs














{{item.name}}会员




